MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
74 hedge funds and large institutions have $131M invested in Marinus Pharmaceuticals, Inc in 2020 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
6% less funds holding
Funds holding: 79 → 74 (-5)
71% less call options, than puts
Call options by funds: $407K | Put options by funds: $1.41M
Holders
74
Holding in Top 10
4
Calls
$407K
Puts
$1.41M
Top Buyers
| 1 | +$3.84M | |
| 2 | +$3.12M | |
| 3 | +$2.54M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.11M |
| 5 |
JPMorgan Chase & Co
New York
|
+$2M |
Top Sellers
| 1 | -$1.65M | |
| 2 | -$398K | |
| 3 | -$195K | |
| 4 |
AC
Aristides Capital
Louisville,
Kentucky
|
-$177K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$157K |